A comparison of the effects of saliva output of oxybutynin chloride and tolterodine tartrate
- 1 May 2001
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (5) , 753-760
- https://doi.org/10.1016/s0149-2918(01)80024-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of OROS®controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloridePublished by Wiley ,2001
- Dry mouth with conventional and controlled-release oxybutynin in urinary incontinenceObstetrics & Gynecology, 2000
- Tolterodine, an Effective and Well Tolerated Treatment for Urge Incontinence and Other Overactive Bladder SymptomsClinical Drug Investigation, 2000
- Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinenceUrology, 1999
- Xerostomia: A Prevalent Condition in the ElderlyEar, Nose & Throat Journal, 1999
- ONCE DAILY CONTROLLED VERSUS IMMEDIATE RELEASE OXYBUTYNIN CHLORIDE FOR URGE URINARY INCONTINENCEJournal of Urology, 1999
- INTRAVESICAL OXYBUTYNIN FOR NEUROGENIC BLADDER DYSFUNCTION: LESS SYSTEMIC SIDE EFFECTS DUE TO REDUCED FIRST PASS METABOLISMJournal of Urology, 1998
- Clinical Implications of the Dry Mouth: Oral Mucosal DiseasesAnnals of the New York Academy of Sciences, 1998
- A Review of the Quality-of-Life Aspects of Urinary Urge IncontinencePharmacoEconomics, 1996
- OxybutyninDrugs & Aging, 1995